[go: up one dir, main page]

NO984190L - FremgangsmÕte for behandling av insomnia - Google Patents

FremgangsmÕte for behandling av insomnia

Info

Publication number
NO984190L
NO984190L NO984190A NO984190A NO984190L NO 984190 L NO984190 L NO 984190L NO 984190 A NO984190 A NO 984190A NO 984190 A NO984190 A NO 984190A NO 984190 L NO984190 L NO 984190L
Authority
NO
Norway
Prior art keywords
insomnia
procedure
treatment
olanzapine
administering
Prior art date
Application number
NO984190A
Other languages
English (en)
Norwegian (no)
Other versions
NO984190D0 (no
Inventor
Pierre V Tran
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9606731.9A external-priority patent/GB9606731D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO984190D0 publication Critical patent/NO984190D0/no
Publication of NO984190L publication Critical patent/NO984190L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO984190A 1996-03-11 1998-09-11 FremgangsmÕte for behandling av insomnia NO984190L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1312696P 1996-03-11 1996-03-11
GBGB9606731.9A GB9606731D0 (en) 1996-03-29 1996-03-29 Method for treating insomnia
PCT/US1997/003592 WO1997033587A1 (en) 1996-03-11 1997-03-07 Method for treating insomnia

Publications (2)

Publication Number Publication Date
NO984190D0 NO984190D0 (no) 1998-09-11
NO984190L true NO984190L (no) 1998-09-11

Family

ID=26309028

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984190A NO984190L (no) 1996-03-11 1998-09-11 FremgangsmÕte for behandling av insomnia

Country Status (15)

Country Link
EP (1) EP0795330A1 (pt)
JP (1) JP2000506528A (pt)
KR (1) KR19990087712A (pt)
CN (1) CN1212627A (pt)
AU (1) AU724245B2 (pt)
BR (1) BR9708181A (pt)
CA (1) CA2248758A1 (pt)
CZ (1) CZ290198A3 (pt)
EA (1) EA000793B1 (pt)
IL (1) IL126160A0 (pt)
NO (1) NO984190L (pt)
NZ (1) NZ331846A (pt)
TR (1) TR199801800T2 (pt)
WO (1) WO1997033587A1 (pt)
YU (1) YU40098A (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA86265C2 (uk) * 2004-09-21 2009-04-10 Хипнион, Инк. Аналог локсапіну та його застосування для регулювання сну

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine

Also Published As

Publication number Publication date
JP2000506528A (ja) 2000-05-30
BR9708181A (pt) 1999-07-27
NZ331846A (en) 2000-07-28
NO984190D0 (no) 1998-09-11
WO1997033587A1 (en) 1997-09-18
CN1212627A (zh) 1999-03-31
CZ290198A3 (cs) 1999-09-15
EA199800818A1 (ru) 1999-02-25
EA000793B1 (ru) 2000-04-24
TR199801800T2 (xx) 1998-12-21
AU2198997A (en) 1997-10-01
AU724245B2 (en) 2000-09-14
CA2248758A1 (en) 1997-09-18
KR19990087712A (ko) 1999-12-27
EP0795330A1 (en) 1997-09-17
YU40098A (sh) 1999-09-27
IL126160A0 (en) 1999-05-09

Similar Documents

Publication Publication Date Title
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
DK0867184T3 (da) Anvendelse af tiagabin til behandling af søvnforstyrrelser
DK0723444T3 (da) Levobupivacain, som er egnet til behandling af kronisk smerte
IL148071A0 (en) Method for treatment of symptoms of central nervous system disorders
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
NO984446L (no) FremgangsmÕte for behandling av smerte
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
NO943372L (no) Behandling av migrene
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
EP1056458A4 (en) PROCESS FOR THE TREATMENT OF PAIN, ESPECIALLY CHRONIC PAIN SPECIFIC TO WOMEN
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
NO984190L (no) FremgangsmÕte for behandling av insomnia
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO984197L (no) FremgangsmÕte for behandling av autisme
NO984198L (no) FremgangsmÕte for behandling av aggresjon
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
NO990436L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
SE9602145D0 (sv) New improved formulation for treatment of thromboembolism
NO985325L (no) Anvendelse av substituert azaspiran ved behandling av astma
UA33531A (uk) Спосіб терапії шизофренії
EA199800820A1 (ru) Способ лечения злоупотребления лекарственными средствами
UA33439A (uk) Спосіб інтенсивного лікування шизофренії
UA32314A (uk) Спосіб лікування некротичного панкреатиту
UA8280A (uk) Спосіб лікування псоріазу

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application